Advisory Services Network’s Cognition Therapeutics CGTX Stock Holding History

Advisory Services Network’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.9K	Buy	+2,500	New	+$2.91K	﹤0.01%	4151
2025 Q4	–	Sell	-2,500	Closed	-$3.38K	–	2229
2025 Q3	$3.38K	Buy	+2,500	New	+$3.41K	﹤0.01%	3662
2024 Q1	–	Sell	-2,500	Closed	-$4.63K	–	1823
2023 Q4	$4.63K	Buy	+2,500	New	+$3.31K	﹤0.01%	3140

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HCM

Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Advisory Services Network's CGTX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Cognition Therapeutics (CGTX) in Q1 2026: 2,500 shares worth $1.9K. The stake represents ﹤0.01% of the portfolio and ranks #4151 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CGTX as recently as Q3 2025.

Advisory Services Network first reported a position in CGTX in Q4 2023 and has held it in 3 quarters since. The position peaked at $4.63K in Q4 2023. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

Advisory Services Network held 2,500 shares of Cognition Therapeutics worth $1.9K as of Q1 2026.
Cognition Therapeutics was a new Advisory Services Network position in Q1 2026.
Cognition Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4151 holding.
Advisory Services Network first reported a position in Cognition Therapeutics in Q4 2023 and has held it in 3 quarters since.
Advisory Services Network's Cognition Therapeutics position peaked at $4.63K in Q4 2023.
75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.